Medications for Recurrent Respiratory Papillomatosis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Recurrent Respiratory Papillomatosis.
Found 1 Approved Drug for Recurrent Respiratory Papillomatosis
Papzimeos
Generic Name
Zopapogene imadenovec
Papzimeos
Generic Name
Zopapogene imadenovec
Form: Injection
Method of administration: Subcutaneous
FDA approval date: August 12, 2025
PAPZIMEOS is indicated for the treatment of adults with recurrent respiratory papillomatosis. PAPZIMEOS™ is a non-replicating adenoviral vector-based immunotherapy indicated for the treatment of adults with recurrent respiratory papillomatosis. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances